Investigating how certain genetic elements and immune responses contribute to Alzheimer's disease
Defining the role of SINE retrotransposons and inflammasome activation in Alzheimer's disease
This study is looking at how certain genetic elements and inflammation in the brain might play a role in Alzheimer's disease, with the hope of finding new ways to treat the condition and help patients feel better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-11089363 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of short interspersed elements (SINEs) and inflammasome activation in the development of Alzheimer's disease (AD). By examining how these genetic elements interact with amyloid-beta plaques and tau aggregates, the study aims to uncover new therapeutic strategies for AD. The researchers will explore the mechanisms by which SINE RNAs may contribute to neurodegeneration and how inhibiting inflammasome activation could potentially mitigate these effects. Patients may benefit from insights that could lead to innovative treatments targeting these pathways.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or those at high risk for developing the condition.
Not a fit: Patients with early-stage cognitive impairment not related to Alzheimer's disease may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic approaches that slow down or prevent the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in targeting inflammasome activation for neurodegenerative diseases, suggesting that this approach may hold potential for Alzheimer's disease as well.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Ambati, Jayakrishna — University of Virginia
- Study coordinator: Ambati, Jayakrishna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.